9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 356 | 1,453 | 119 | 97 | N/A |
| Receivables | 75 | 856 | 644 | 3,569 | N/A |
| Inventories | N/A | 1,105 | 633 | 2,587 | N/A |
| Other current assets | 160 | 0 | 0 | 0 | 0 |
| TOTAL | $752 | $4,033 | $1,537 | $6,321 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 41 | N/A | N/A | N/A | N/A |
| Intangibles | 0 | 2,417 | 2,548 | 0 | 0 |
| Other Non-Current Assets | 6 | 14 | 633 | 90 | 0 |
| TOTAL | $46 | $2,431 | $3,181 | $90 | $N/A |
| Total Assets | $799 | $6,464 | $4,718 | $6,411 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 215 | 5,051 | N/A |
| Accounts payable and accrued liabilities | 2,659 | 312 | 1,531 | 2,115 | 0 |
| Accrued Expenses | 1,180 | 1,786 | 3,311 | 4,198 | N/A |
| Other current liabilities | N/A | 1,840 | 1,850 | N/A | N/A |
| TOTAL | $12,973 | $3,976 | $10,412 | $11,399 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,973 | $3,976 | $10,412 | $11,399 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,285 | 40 | N/A | N/A | N/A |
| Common Shares | 12 | 1 | N/A | 0 | N/A |
| Retained earnings | -19,354 | -32,088 | -25,875 | -17,134 | N/A |
| TOTAL | $-12,175 | $2,488 | $-5,694 | $-4,988 | $N/A |
| Total Liabilities And Equity | $799 | $6,464 | $4,718 | $6,411 | $0 |